Anna-Lena Wennberg1,2, Kenny A Rodriguez-Wallberg3,4, Ian Milsom1, Mats Brännström1,5. 1. Department of Obstetrics and Gynecology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. 2. Nordic IVF Centre Göteborg, Gothenburg, Sweden. 3. Department of Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden. 4. Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. 5. Stockholm IVF, Stockholm, Sweden.
Abstract
INTRODUCTION: Novel pathways to parenthood [oocyte cryopreservation, allowance of surrogacy, uterus transplantation, and assisted reproductive treatments (ART) for single women] are currently being discussed. This study investigates women's attitudes towards oocyte cryopreservation and ART procedures that are not allowed or are still under investigation in Sweden, and whether the attitudes differ between urban women and women from a national cohort. MATERIALS AND METHODS: Two thousand randomly selected Swedish females aged 30-39 years, 1000 residents of Stockholm (urban cohort) and 1000 from the remainder of Sweden (national cohort), were invited to complete a postal questionnaire on attitudes about existing and novel ARTs. RESULTS: Response rates for the national and urban cohorts were 52.1% and 48.9%. Ninety-four per cent of women were positive towards oocyte cryopreservation for medical reasons. Seventy per cent considered that this treatment was also indicated for social reasons. Seventy-six per cent found it acceptable to offer ART to single women. Uterus transplantation was found to be more acceptable than surrogacy (80% vs. 47%). Urban women were more positive to both oocyte cryopreservation for social reasons and fertility treatment of single women than the national cohort. Urban women were also more tolerant regarding age limits for attempting pregnancy with cryopreserved gametes and regarding permission for a longer duration of maintaining cryopreserved gametes. CONCLUSIONS: Swedish women have a high acceptance of most new ARTs, with the exception of surrogacy. Urban women seem to have a greater acceptance for social egg-freezing, longer duration of cryopreservation of oocytes, and higher age limit for their use.
INTRODUCTION: Novel pathways to parenthood [oocyte cryopreservation, allowance of surrogacy, uterus transplantation, and assisted reproductive treatments (ART) for single women] are currently being discussed. This study investigates women's attitudes towards oocyte cryopreservation and ART procedures that are not allowed or are still under investigation in Sweden, and whether the attitudes differ between urban women and women from a national cohort. MATERIALS AND METHODS: Two thousand randomly selected Swedish females aged 30-39 years, 1000 residents of Stockholm (urban cohort) and 1000 from the remainder of Sweden (national cohort), were invited to complete a postal questionnaire on attitudes about existing and novel ARTs. RESULTS: Response rates for the national and urban cohorts were 52.1% and 48.9%. Ninety-four per cent of women were positive towards oocyte cryopreservation for medical reasons. Seventy per cent considered that this treatment was also indicated for social reasons. Seventy-six per cent found it acceptable to offer ART to single women. Uterus transplantation was found to be more acceptable than surrogacy (80% vs. 47%). Urban women were more positive to both oocyte cryopreservation for social reasons and fertility treatment of single women than the national cohort. Urban women were also more tolerant regarding age limits for attempting pregnancy with cryopreserved gametes and regarding permission for a longer duration of maintaining cryopreserved gametes. CONCLUSIONS: Swedish women have a high acceptance of most new ARTs, with the exception of surrogacy. Urban women seem to have a greater acceptance for social egg-freezing, longer duration of cryopreservation of oocytes, and higher age limit for their use.
Authors: Alexandra S Rashedi; Saskia F de Roo; Lauren M Ataman; Maxwell E Edmonds; Adelino Amaral Silva; Anibal Scarella; Anna Horbaczewska; Antoinette Anazodo; Ayse Arvas; Bruno Ramalho de Carvalho; Cassio Sartorio; Catharina C M Beerendonk; Cesar Diaz-Garcia; Chang Suk Suh; Cláudia Melo; Claus Yding Andersen; Eduardo Motta; Ellen M Greenblatt; Ellen Van Moer; Elnaz Zand; Fernando M Reis; Flor Sánchez; Guillermo Terrado; Jhenifer K Rodrigues; Joao Marcos de Meneses E Silva; Johan Smitz; Jose Medrano; Jung Ryeol Lee; Katharina Winkler-Crepaz; Kristin Smith; Lígia Helena Ferreira Melo E Silva; Ludwig Wildt; Mahmoud Salama; María Del Mar Andrés; Maria T Bourlon; Mario Vega; Maurício Barbour Chehin; Michel De Vos; Mohamed Khrouf; Nao Suzuki; Osama Azmy; Paula Fontoura; Paulo Henrique Almeida Campos-Junior; Peter Mallmann; Ricardo Azambuja; Ricardo M Marinho; Richard A Anderson; Robert Jach; Roberto de A Antunes; Rod Mitchell; Rouhollah Fathi; Satish Kumar Adiga; Seido Takae; Seok Hyun Kim; Sergio Romero; Silvana Chedid Grieco; Talya Shaulov; Tatsuro Furui; Teresa Almeida-Santos; Willianne Nelen; Yasmin Jayasinghe; Yodo Sugishita; Teresa K Woodruff Journal: J Glob Oncol Date: 2017-06-30
Authors: Benjamin P Jones; Abirami Rajamanoharan; Nicola J Williams; Saaliha Vali; Srdjan Saso; Ifigenia Mantrali; Maria Jalmbrant; Meen-Yau Thum; Cesar Diaz-Garcia; Sadaf Ghaem-Maghami; Stephen Wilkinson; Isabel Quiroga; Peter Friend; Joseph Yazbek; J Richard Smith Journal: Transplant Direct Date: 2021-02-18